loading...| Preferred Name |
methoxy polyethylene glycol epoetin beta |
|
| Synonyms |
Methoxypolyethylene Glycol Epoetin Beta |
|
| Definitions |
A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Methoxypolyethylene glycol epoetin beta may reverse anemias induced by cancer therapy. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C38687" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38687" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000339378 |
|
| altLabel |
Methoxypolyethylene Glycol Epoetin Beta Mircera Ro 50-3821 |
|
| cui |
C1328706 C1328071 C1996332 |
|
| DATE FIRST PUBLISHED |
2003-10-25 |
|
| Date last modified |
2008-05-23 |
|
| definition |
A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Methoxypolyethylene glycol epoetin beta may reverse anemias induced by cancer therapy. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C38687" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C38687" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C38687 |
|
| notation |
CDR0000339378 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
methoxy polyethylene glycol epoetin beta |
|
| tui |
T109 T116 T121 |